Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Protein transduction by pseudotyped lentivirus-like nanoparticles

Abstract

A simple, efficient and reproducible method to transduce proteins into mammalian cells has not been established. Here we describe a novel protein transduction method based on a lentiviral vector. We have developed a method to package several thousand foreign protein molecules into a lentivirus-like nanoparticle (LENA) and deliver them into mammalian cells. In this proof-of-concept study, we used β-lactamase (BlaM) as a reporter molecule. The amino-terminus of BlaM was fused to the myristoylation signal of lyn, which was placed upstream of the amino-terminus of Gag (BlaM-gag-pol). By co-transfection of plasmids encoding BlaM-gag-pol and vesicular stomatitis virus-G (VSV-G) into 293T cells, LENA were produced containing BlaM enzyme molecules as many as Gag per capsid, which has been reported to be 5000 molecules, but lacking the viral genome. Infection of 293T and MT-4 cells by VSV-G-pseudotyped BlaM-containing LENA led to successful transduction of BlaM molecules into the cell cytoplasm, as detected by cleavage of the fluorescent BlaM substrate CCF2-AM. LENA-mediated transient protein transduction does not damage cellular DNA, and the preparation of highly purified protein is not necessary. This technology is potentially useful in various basic and clinical applications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. MacGregor RR . Clinical protocol. A phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects. Hum Gene Ther 2001; 12: 2028–2029.

    CAS  PubMed  Google Scholar 

  2. Cockrell AS, Kafri T . Gene delivery by lentivirus vectors. Mol Biotechnol 2007; 36: 184–204.

    Article  CAS  PubMed  Google Scholar 

  3. McCart JA, Bartlett DI . Lentiviral Vectors. In: Templeton NS (ed.). Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, 3rd edn. CRC Press: Carrollton, 2008, pp 245–262.

    Google Scholar 

  4. Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N et al. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther 2008; 8: 461–473.

    Article  CAS  PubMed  Google Scholar 

  5. Jacks T, Power MD, Masiarz FR, Luciw PA, Barr PJ, Varmus HE . Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 1988; 331: 280–283.

    Article  CAS  PubMed  Google Scholar 

  6. Klein KC, Reed JC, Lingappa JR . Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Rev 2007; 9: 150–161.

    PubMed  Google Scholar 

  7. Briggs JA, Simon MN, Gross I, Kräusslich HG, Fuller SD, Vogt VM et al. The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 2004; 11: 672–675.

    Article  CAS  PubMed  Google Scholar 

  8. Wyma DJ, Jiang J, Shi J, Zhou J, Lineberger JE, Miller MD et al. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J Virol 2004; 78: 3429–3435.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Urano E, Aoki T, Futahashi Y, Murakami T, Morikawa Y, Yamamoto N et al. Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-delta1 pleckstrin homology domain results in infectious pseudovirion production. J Gen Virol 2008; 89: 3144–3149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Aoki T, Shimizu S, Urano E, Futahashi Y, Hamatake M, Tamamura H et al. Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55(Gag). Gene Therapy 2010; 17: 1124–1133.

    Article  CAS  PubMed  Google Scholar 

  11. Voelkel C, Galla M, Maetzig T, Warlich E, Kuehle J, Zychlinski D et al. Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci USA 2010; 107: 7805–7810.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hubner W, Chen P, Del Portillo A, Liu Y, Gordon RE, Chen BK . Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1. J Virol 2007; 81: 12596–12607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Campbell RE . Realization of beta-lactamase as a versatile fluorogenic reporter. Trends Biotechnol 2004; 22: 208–211.

    Article  CAS  PubMed  Google Scholar 

  14. Wagner R, Graf M, Bieler K, Wolf H, Grunwald T, Foley P et al. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther 2000; 11: 2403–2413.

    Article  CAS  PubMed  Google Scholar 

  15. Ulett GA, Han S, Han JS . Electroacupuncture: mechanisms and clinical application. Biol Psychiatry 1998; 44: 129–138.

    Article  CAS  PubMed  Google Scholar 

  16. Ford KG, Souberbielle BE, Darling D, Farzaneh F . Protein transduction: an alternative to genetic intervention? Gene Therapy 2001; 8: 1–4.

    Article  CAS  PubMed  Google Scholar 

  17. Zhang Y, Yu LC . Microinjection as a tool of mechanical delivery. Curr Opin Biotechnol 2008; 19: 506–510.

    Article  CAS  PubMed  Google Scholar 

  18. Cavrois M, De Noronha C, Greene WC . A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 2002; 20: 1151–1154.

    Article  CAS  PubMed  Google Scholar 

  19. Yamanaka S, Blau HM . Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010; 465: 704–712.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Komano J, Miyauchi K, Matsuda Z, Yamamoto N . Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol Biol Cell 2004; 15: 5197–5207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Stauffer TP, Ahn S, Meyer T . Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr Biol 1998; 8: 343–346.

    Article  CAS  PubMed  Google Scholar 

  22. Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z . Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J Virol 2005; 79: 4720–4729.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the Japan Health Science Foundation, the Japanese Ministry of Health, Labor, and Welfare (H18-AIDS-W-003 to JK) and the Japanese Ministry of Education, Culture, Sports, Science and Technology (18689014 and 18659136 to JK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Komano.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aoki, T., Miyauchi, K., Urano, E. et al. Protein transduction by pseudotyped lentivirus-like nanoparticles. Gene Ther 18, 936–941 (2011). https://doi.org/10.1038/gt.2011.38

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2011.38

Keywords

This article is cited by

Search

Quick links